[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial

Scott T Tagawa, Oliver Sartor, Josep M Piulats, Fred Saad, Karim Fizazi, Alison Reid, Himisha Beltran, Gero Kramer, Hakim Mahammedi, Matthias Eiber, Shilpa Gupta, Daniel Castellano, Ralph Hauke, Hyun Kim, Cheol Kwak, See Tong Pang, Philippe Barthélémy, Dong Dai, Jae Lyun Lee, Luke Nordquist, Russell Z Szmulewitz, Paweł Wiechno, Alejandro Yovine, Lauren Smith, Emmanuel Bouillaud, Olga Sakharova, Michael J Morris

Open source

DOI: 10.1016/s0140-6736(26)01092-5
Published: 2026-08
Container: The Lancet
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-26-01092-5,
  title = {[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial},
  author = {Scott T Tagawa and Oliver Sartor and Josep M Piulats and Fred Saad and Karim Fizazi and Alison Reid and Himisha Beltran and Gero Kramer and Hakim Mahammedi and Matthias Eiber and Shilpa Gupta and Daniel Castellano and Ralph Hauke and Hyun Kim and Cheol Kwak and See Tong Pang and Philippe Barthélémy and Dong Dai and Jae Lyun Lee and Luke Nordquist and Russell Z Szmulewitz and Paweł Wiechno and Alejandro Yovine and Lauren Smith and Emmanuel Bouillaud and Olga Sakharova and Michael J Morris},
  year = {2026},
  journal = {The Lancet},
  doi = {10.1016/s0140-6736(26)01092-5},
  url = {https://doi.org/10.1016/s0140-6736(26)01092-5}
}

RIS

TY  - JOUR
TI  - [177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial
AU  - Scott T Tagawa
AU  - Oliver Sartor
AU  - Josep M Piulats
AU  - Fred Saad
AU  - Karim Fizazi
AU  - Alison Reid
AU  - Himisha Beltran
AU  - Gero Kramer
AU  - Hakim Mahammedi
AU  - Matthias Eiber
AU  - Shilpa Gupta
AU  - Daniel Castellano
AU  - Ralph Hauke
AU  - Hyun Kim
AU  - Cheol Kwak
AU  - See Tong Pang
AU  - Philippe Barthélémy
AU  - Dong Dai
AU  - Jae Lyun Lee
AU  - Luke Nordquist
AU  - Russell Z Szmulewitz
AU  - Paweł Wiechno
AU  - Alejandro Yovine
AU  - Lauren Smith
AU  - Emmanuel Bouillaud
AU  - Olga Sakharova
AU  - Michael J Morris
PY  - 2026
JO  - The Lancet
DO  - 10.1016/s0140-6736(26)01092-5
UR  - https://doi.org/10.1016/s0140-6736(26)01092-5
ER  -

APA

Tagawa, S. T., Sartor, O., Piulats, J. M., Saad, F., Fizazi, K., Reid, A., Beltran, H., Kramer, G., Mahammedi, H., Eiber, M., Gupta, S., Castellano, D., Hauke, R., Kim, H., Kwak, C., Pang, S. T., Barthélémy, P., Dai, D., Lee, J. L., Nordquist, L., Szmulewitz, R. Z., Wiechno, P., Yovine, A., Smith, L., Bouillaud, E., Sakharova, O., & Morris, M. J. (2026). [177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial. The Lancet. https://doi.org/10.1016/s0140-6736(26)01092-5

Source records

crossref · retrieved 2026-11-10T12:12:05.519Z